Understanding firm, physician and consumer choice behavior in the pharmaceutical industry

P Manchanda; DR Wittink; A Ching; P Cleanthous; M Ding; XJJ Dong; PSH Leeflang; S Misra; N Mizik; S Narayanan; T Steenburgh; JE Wieringa; M Wosinska; Y Xie

doi:10.1007/s11002-005-5893-1

Understanding firm, physician and consumer choice behavior in the pharmaceutical industry

P Manchanda^*, DR Wittink, A Ching, P Cleanthous, M Ding, XJJ Dong, PSH Leeflang, S Misra, N Mizik, S Narayanan, T Steenburgh, JE Wieringa, M Wosinska, Y Xie

^*Bijbehorende auteur voor dit werk

Onderzoeksoutput: Article › Academic › peer review

36 Citaten (Scopus)

Samenvatting

This paper argues that the pharmaceutical industry represents an exciting opportunity to carry out academic research. The nature of the industry allows researchers to answer new questions, develop new methodologies for answering these questions as well as to apply existing methodology to new data. The paper opens with some industry background, then provides a brief overview of some important research areas and discusses the open questions in each area. Issues of data type and availability are also discussed.

Originele taal-2	English
Pagina's (van-tot)	293-308
Aantal pagina's	16
Tijdschrift	Marketing Letters
Volume	16
Nummer van het tijdschrift	3-4
DOI's	https://doi.org/10.1007/s11002-005-5893-1
Status	Published - dec.-2005
Evenement	6th Triennial Invitational Choice Symposium - Boulder, Colombia Duur: 4-jun.-2004 → 8-jun.-2004

Toegang tot document

10.1007/s11002-005-5893-1

Handle.net

Permanente koppeling

Document onder embargo

Understanding firm, physician and consumer choice behavior in the pharmaceutical
Final publisher's version, 145 KB
Kopie aanvragen

Citeer dit

@article{8169bfec6d914a2cb8884d1c7458b358,

title = "Understanding firm, physician and consumer choice behavior in the pharmaceutical industry",

abstract = "This paper argues that the pharmaceutical industry represents an exciting opportunity to carry out academic research. The nature of the industry allows researchers to answer new questions, develop new methodologies for answering these questions as well as to apply existing methodology to new data. The paper opens with some industry background, then provides a brief overview of some important research areas and discusses the open questions in each area. Issues of data type and availability are also discussed.",

keywords = "pharmaceutical marketing, patient compliance, response models, new products, physician networks, pharmaceutical pricing, SOCIAL CONTAGION, DIFFUSION, MODEL, INNOVATION, DRUGS",

author = "P Manchanda and DR Wittink and A Ching and P Cleanthous and M Ding and XJJ Dong and PSH Leeflang and S Misra and N Mizik and S Narayanan and T Steenburgh and JE Wieringa and M Wosinska and Y Xie",

year = "2005",

month = dec,

doi = "10.1007/s11002-005-5893-1",

language = "English",

volume = "16",

pages = "293--308",

journal = "Marketing Letters",

issn = "0923-0645",

publisher = "SPRINGER",

number = "3-4",

note = "6th Triennial Invitational Choice Symposium ; Conference date: 04-06-2004 Through 08-06-2004",

}

TY - JOUR

T1 - Understanding firm, physician and consumer choice behavior in the pharmaceutical industry

AU - Manchanda, P

AU - Wittink, DR

AU - Ching, A

AU - Cleanthous, P

AU - Ding, M

AU - Dong, XJJ

AU - Leeflang, PSH

AU - Misra, S

AU - Mizik, N

AU - Narayanan, S

AU - Steenburgh, T

AU - Wieringa, JE

AU - Wosinska, M

AU - Xie, Y

PY - 2005/12

Y1 - 2005/12

N2 - This paper argues that the pharmaceutical industry represents an exciting opportunity to carry out academic research. The nature of the industry allows researchers to answer new questions, develop new methodologies for answering these questions as well as to apply existing methodology to new data. The paper opens with some industry background, then provides a brief overview of some important research areas and discusses the open questions in each area. Issues of data type and availability are also discussed.

AB - This paper argues that the pharmaceutical industry represents an exciting opportunity to carry out academic research. The nature of the industry allows researchers to answer new questions, develop new methodologies for answering these questions as well as to apply existing methodology to new data. The paper opens with some industry background, then provides a brief overview of some important research areas and discusses the open questions in each area. Issues of data type and availability are also discussed.

KW - pharmaceutical marketing

KW - patient compliance

KW - response models

KW - new products

KW - physician networks

KW - pharmaceutical pricing

KW - SOCIAL CONTAGION

KW - DIFFUSION

KW - MODEL

KW - INNOVATION

KW - DRUGS

U2 - 10.1007/s11002-005-5893-1

DO - 10.1007/s11002-005-5893-1

M3 - Article

SN - 0923-0645

VL - 16

SP - 293

EP - 308

JO - Marketing Letters

JF - Marketing Letters

IS - 3-4

T2 - 6th Triennial Invitational Choice Symposium

Y2 - 4 June 2004 through 8 June 2004

ER -